tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Cannabis'

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

SEATTLE, WA — October 29, 2014 — Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that Uruguay’s Ministry of Public Health has approved an academic collaboration between Plandaí and the Group of Medicinal Chemistry from the School of Science at the University of the Republic (“University”) in Montevideo, Uruguay.  The approval, issued in September 2014, allows Plandaí to grow cannabis in conjunction with ...

Read More →
0

Nuvilex Applies to FDA for Orphan Drug Designation for Its Cell-in-a-Box Treatment for Pancreatic Cancer

Silver Spring, MD — October 13, 2014 — Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company developing cell therapy solutions for the treatment of diseases, announced today that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Orphan Drug Designation for its Cell-in-a-Box® treatment for pancreatic cancer. If granted, Orphan Drug Designation in the United States will provide Nuvilex special development and commercial assistance from the FDA, including a 7 year period of marketing exclusivity. ...

Read More →
0

XTRM Cannabis Ventures Emerging as Strong Player in Burgeoning Marijuana Industry

XTRM Cannabis Ventures Emerging as Strong Player in Burgeoning Marijuana Industry

Written by ι Stock Market Media Group Staff — February 18, 2014

Extreme Biodiesel, Inc. (OTC Pink: XTRM) may have just entered the marijuana industry in 2014 with its wholly owned subsidiary, XTRM Cannabis Ventures, but it’s already emerging as a company that will have a significant footprint in the arena.  The company’s timing is impeccable as a number of recent moves by the Obama Administration and legislators in Washington dramatically favor both Extreme Biodiesel and XTRM Cannabis’s business plans. 

Extreme Biodiesel is actually ...

Read More →
0

Marijuana Entrepreneur Jamen Shively Goes Public with Plandai Biotechnology, Inc.

Marijuana Entrepreneur Jamen Shively Goes Public with Plandai Biotechnology, Inc.

Written by ι Stock Market Media Group — February 14, 2014

If Plandaí Biotechnology (OTCQB: PLPL) investors liked the idea of Diego Pellicer co-founder Jamen Shively working with the company from the outside, then they’ll love the idea that he’s now on the inside of this public biotech.  Jamen Shively, a former Microsoft executive turned marijuana entrepreneur, has gone public being named to the Board of Directors at Plandaí. 

His experience at Microsoft alone makes this a great business move, but the media’s attraction ...

Read More →
0

Congressional Legislators Agree with Nuvilex’s Dr. Mark Rabe on Reclassifying Marijuana

Written by ι Stock Market Media Group — February 14, 2014

Nuvilex, Inc.’s (OTCQB: NVLX) Dr. Mark L. Rabe has something in common with 18 members of Congress.  All of them want marijuana reclassified from its current listing as a dangerous drug with no medical value, and they want President Obama to use his authority to make that change by removing marijuana from the Schedule I category.  Currently marijuana is viewed in the same category as drugs like heroin and LSD, and in ...

Read More →
0

Nuvilex’s Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box

Nuvilex’s Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box

Written by ι Stock Market Media Group — February 12, 2014

Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that’s focused on getting into late phase clinical trials for the treatment of advanced, inoperable pancreatic cancer, but it also expects to be a major player in the medical marijuana arena.  And, to that end, last December, Nuvilex landed a leading figure in the medical marijuana field in Dr. Mark L. Rabe.  Dr. Rabe was appointed as the Chairman of the Scientific Advisory Board ...

Read More →
0
Page 2 of 4 1234
ContactUs.com